A seismic shift occurred in the Philippine economic landscape in January 2024 with the appointment of Ralph Recto as Secretary of Finance. Replacing Benjamin Diokno, Recto wasn’t chosen for mere political expediency, but for a proven ability to forge consensus and navigate the complex currents of Congress – skills deemed vital for enacting the administration’s economic vision.
Recto’s background is a tapestry of legislative and executive experience. He served three terms in the Senate, rising to positions of leadership, and multiple terms as a Representative. Before assuming his new role, he also held the influential post of Socioeconomic Planning Secretary and Director-General of the National Economic and Development Authority, shaping national policy during the Arroyo presidency.
Just months into his tenure, Secretary Recto authorized a significant financial maneuver: the transfer of ₱89.9 billion from PhilHealth’s coffers to the national treasury. This wasn’t a simple accounting adjustment, but a move dictated by a provision within the 2024 General Appropriations Act, allowing the use of “excess” funds from government corporations.
The transfer unfolded in stages throughout 2024 – ₱20 billion in May, ₱10 billion in August, and ₱30 billion in October. A final tranche of ₱29.9 billion was slated for November, but a dramatic intervention by the Supreme Court, issuing a Temporary Restraining Order, brought the process to a halt.
The very nature of these funds sparked intense debate. Were they a government subsidy, simply excess, unspent, or a crucial reserve? The distinction is critical. If a subsidy, it wasn’t directed *to* PhilHealth, but to over 38 million Filipinos – the indigent, seniors, people with disabilities – representing their collectively paid premiums for healthcare access.
Removing ₱89.9 billion from PhilHealth, critics argued, effectively cancelled the premium payments of these vulnerable citizens, violating the spirit and letter of the Universal Health Care Act of 2019. For an insurance entity, a reserve isn’t idle money; it’s a safeguard against future claims, a promise of solvency.
Retired Supreme Court Justice Antonio Carpio emerged as a vocal opponent, asserting the transfer was unconstitutional and potentially criminal. He argued the power to reallocate appropriations rests solely with the President, and these funds – sourced from member contributions and “sin” taxes – were designated for a specific purpose: universal healthcare.
Carpio warned of personal liability for Secretary Recto should the Supreme Court deem the transfer illegal, potentially requiring him to return the already disbursed ₱60 billion. He emphasized the funds were intended for healthcare, not diverted to other government projects.
Secretary Recto countered before the Supreme Court, defending the move as legal, ethical, and economically prudent. He maintained it adhered to the Congressional mandate within the 2024 General Appropriations Act to utilize idle funds from government-owned corporations.
The remitted funds, he explained, were allocated to critical areas: ₱27.45 billion for Public Health Emergency Benefits during the pandemic, ₱10 billion for medical assistance to the impoverished, and billions more for medical equipment, facility construction, and health worker allowances.
However, the legality hinged on the interpretation of the Universal Health Care Act itself. Critics contend the law, despite its name, doesn’t guarantee truly universal access. True universal healthcare requires a robust, government-owned healthcare infrastructure – hospitals and clinics staffed by public employees – something the Philippines currently lacks.
The Act, some argue, was rushed into law to serve as a political talking point during the 2019 elections, authored by senators seeking re-election. While it automatically enrolled citizens in PhilHealth, the reality is that PhilHealth covers only around 40% of hospital bills, according to studies.
Fundamental issues plague PhilHealth’s structure. Its board lacked individuals with substantive insurance experience, hindering sound policy formulation. Even Health Secretary Herbosa, Chairman of the board, demonstrated a concerning lack of understanding of PhilHealth’s operations, questioning why funds were invested rather than immediately spent.
The organization also lacks crucial personnel – particularly a qualified health insurance actuary and a competent investment manager. This deficiency, coupled with a misunderstanding of basic healthcare terminology, raises serious concerns about its ability to effectively manage the nation’s healthcare finances.
During oral arguments, a Supreme Court Justice bluntly suggested a complete overhaul of PhilHealth and its board, citing non-compliance with legal requirements. While Secretary Recto and the board may not have personally profited, the legal violations are undeniable, demanding accountability. The principle of “no one is above the law” remains paramount.
Now, with Recto appointed as Executive Secretary, the implications of this case extend beyond the immediate financial dispute. The future of PhilHealth, and the promise of universal healthcare for all Filipinos, hangs in the balance, awaiting the final judgment of the Supreme Court and a renewed commitment to sound governance.
Oscar P. Lagman, Jr., a long-time observer of Philippine politics, continues to follow these developments with keen interest.
